MCM
Marathon Capital Management Portfolio holdings
AUM
$465M
1-Year Est. Return
21.5%
This Fund
S&P 500
1 Year Est. Return
+21.5%
AUM
$437M
AUM Growth
+$44.4M
(+11%)
Holding
180
Top Buys
| 1 | +$7.74M | |
| 2 | +$4.47M | |
| 3 | +$3.36M | |
| 4 |
ADMA Biologics
ADMA
|
+$3.13M |
| 5 |
PAR Technology
PAR
|
+$2.96M |
Top Sells
| 1 | +$3.37M | |
| 2 | +$2.47M | |
| 3 | +$2.04M | |
| 4 |
Corning
GLW
|
+$1.04M |
| 5 |
Calix
CALX
|
+$946K |
Sector Composition
| 1 | Financials | 24.76% |
| 2 | Technology | 21.1% |
| 3 | Healthcare | 12.26% |
| 4 | Industrials | 9.94% |
| 5 | Energy | 8.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.67B
| – | – |
0
|
|
||
177
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.76B
| – | – |
0
|
|
||
178
Kraft Heinz
KHC
$26.4B
| – | – |
-7,900
|
|
||
179
Philip Morris
PM
$244B
| – | – |
-1,412
|
|
||
180
Sarepta Therapeutics
SRPT
$2.35B
| – | – |
-41,575
|
|